Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 1;47(2):172-173.
doi: 10.1097/RLU.0000000000003924.

Renal Infarction Imaged With [18F]Prostate-Specific Membrane Antigen-1007 PET/CT

Niloefar Ahmadi Bidakhvidi  1 , Amaryllis H Van Craenenbroeck, Raymond Oyen  2 , Koen Van Laere, Karolien Goffin
Affiliations

Renal Infarction Imaged With [18F]Prostate-Specific Membrane Antigen-1007 PET/CT

Niloefar Ahmadi Bidakhvidi et al. Clin Nucl Med. .

Abstract

A 61-year-old post-renal transplant man developed pain in the region of the allograft 4 days after transplantation. Contrast-enhanced CT scan revealed multiple small perfusion defects in the renal graft cortex. Multifocal renal cortical infarction was suspected. A [99mTc]Tc-DMSA SPECT/CT showed several small regions with decreased uptake. In addition, an [18F]PSMA-1007 PET/CT confirmed these uptake defects and revealed additional defects. The renal cortical infarctions presumably originated from intraoperative emboli emerging from the arterial anastomosis. Treatment with acetylsalicylic acid 100 mg led to favorable evolution of the renal function biochemically. Follow-up DMSA scintigraphy 3 months later showed resolution of the renal cortical defects.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest and sources of funding: none declared.

References

    1. Rahbar K, Afshar-Oromieh A, Seifert R, et al. Diagnostic performance of (18)F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer. Eur J Nucl Med Mol Imaging . 2018;45:2055–2061.
    1. Cytawa W, Seitz AK, Kircher S, et al. 68 Ga-PSMA I&T PET/CT for primary staging of prostate cancer. Eur J Nucl Med Mol Imaging . 2020;47:168–177.
    1. de Galiza Barbosa F, Queiroz MA, Nunes RF, et al. Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings. Cancer Imaging . 2020;20:23.
    1. Marafi F, Sasikumar A, Al-Terki A, et al. 18 F-PSMA 1007 in suspected renal cell carcinoma. Clin Nucl Med . 2020;45:377–378.
    1. Sarikaya I, Elgazzar AH, Alfeeli MA, et al. Can gallium-68 prostate-specific membrane antigen ligand be a potential radiotracer for renal cortical positron emission tomography imaging? World J Nucl Med . 2018;17:126–129.

LinkOut - more resources